[Prognostic factors in the chemotherapy of bronchial cancers].
D000230:Adenocarcinoma / Q000188:drug therapy; D000367:Age Factors; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001984:Bronchial Neoplasms / Q000188:drug therapy*; D002277:Carcinoma / Q000188:drug therapy; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy*; D018288:Carcinoma, Small Cell / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D008175:Lung Neoplasms / Q000188:drug therapy*; D008727:Methotrexate / Q000627:therapeutic use*; D009362:Neoplasm Metastasis; D011344:Procarbazine / Q000627:therapeutic use*; D011379:Prognosis; D012075:Remission, Spontaneous; D014750:Vincristine / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D004338:Drug Combinations; D011344:Procarbazine; D014750:Vincristine; D003520:Cyclophosphamide; D008727:Methotrexate
Facteurs pronostiques dans la chimiothérapie des cancers bronchiques.